Search
Salarius Pharmaceuticals Ord Shs
DCOYAdd to Watchlist
3.100USD
+0.540+21.09%
Close 09-22 16:00（ET）
1.64MMarket Cap
LossP/E TTM
Pre-market 07:19 (ET)4.380USD+1.280+41.29%
Pre-market 07:19 (ET)DCOY Financials
See Salarius Pharmaceuticals Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
1.64M
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
-1.97K
Revenue
--
Net Profit
-5.58M
ROE
-661.73%
ROA
-242.20%
Salarius Pharmaceuticals Ord Shs Earnings Date
Latest Release
Aug 12, 2026
EPS / Forecast
-4.46/--
Revenue / Forecast
--/--
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its current assets were 10.99M, with a year-on-year change of 267.70.
What are the total assets of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its total assets of Salarius Pharmaceuticals Ord Shs were 11.06M, with a year-on-year change of 265.76.
What are the total liabilities of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its total liabilities of Salarius Pharmaceuticals Ord Shs were 5.17M, with a year-on-year change of 241.94.
What is the total equity of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its total equity of Salarius Pharmaceuticals Ord Shs was 5.89M, with a year-on-year change of 289.56.
What is the net operating income of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its net operating income of Salarius Pharmaceuticals Ord Shs was -4.10M, with a year-on-year change of 28.57.
What is the net financing of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its net financing of Salarius Pharmaceuticals Ord Shs was 12.34M, with a year-on-year change of 1064.00.
What is the Earnings Per Share (EPS) of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -1549.21, with a year-on-year change of -48.53.
What is the net income of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its net income was -12.52M, with a year-on-year change of -124.52.
What is the Return on Equity (ROE) of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -338.31, with a year-on-year change of -106.26.
What is the Return on Assets (ROA) of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -177.82, with a year-on-year change of -53.23.
What is the operating profit of Salarius Pharmaceuticals Ord Shs?
According to Salarius Pharmaceuticals Ord Shs's FY2025 earnings report, its operating profit was -4.10M, with a year-on-year change of 28.57.